wordmark

Benchling and Lilly TuneLab partner to democratize access to ai models for scientists everywhere

Benchling has partnered with Lilly TuneLab to bring AI models trained on over $1 billion in Lilly research data directly into scientists' workflows. Run prediction models for antibodies and small molecules, then share data back for federated learning — all without leaving Benchling. Reach out to your Benchling account team for access & information.

Run Lilly TuneLab prediction models, directly from Benchling

Access

What is Lilly TuneLab? Lilly's proprietary AI models, built for drug discovery

Eli Lilly created TuneLab to give biotech companies access to their proprietary drug discovery models, built from decades of research data and hundreds of thousands of experimental molecules. TuneLab levels the playing field, bringing AI capabilities that Lilly scientists use daily to companies of all sizes.

  • AI/ML models for in silico property predictions across small molecules and antibodies

  • Built on secure federated learning—your data stays private

  • Models continuously improve as more companies participate

What is Lilly TuneLab? Lilly's proprietary AI models, built for drug discovery
Integrated

Why TuneLab at Benchling? Predictions where your science already happens

Benchling is the platform where scientists already capture, connect, and analyze R&D data. TuneLab at Benchling means predictions flow directly into your existing workflows—no data exports, no context switching, no disconnected tools.

  • Run predictions directly from your Benchling Notebook and Registry

  • Results automatically linked to your sequences, molecules, and experimental metadata

  • Outputs are traceable and ready for downstream analysis

Why TuneLab at Benchling?
Ecosystem

Expanding Benchling Models: TuneLab joins Benchling's growing scientific AI ecosystem

TuneLab expands Benchling Models, our centralized hub where scientists access the world's leading scientific AI. Alongside structure prediction models like AlphaFold, Chai, and Boltz, TuneLab brings Lilly's proprietary drug disposition and safety models directly into your workflows.

  • Part of Benchling AI, alongside our partnerships with Anthropic, NVIDIA, and others

  • One place to access open-source and proprietary scientific models

  • Connected to your structured data for predictions that drive decisions

Expanding Benchling Models: TuneLab joins Benchling's growing scientific AI ecosystem
Benchling Logo
Lilly chose Benchling as a priority platform partner for TuneLab distribution…Their collaborative AI model will reach scientists around the world. We're building the infrastructure that makes sophisticated AI accessible to the entire industry.
Sajith Wickramasekara

CEO and co-founder of Benchling

Three steps to AI-powered predictions

Join our early access list for TuneLab today.

  • Send us an email at support@benchling.com with your company info and use case

  • We'll confirm your Benchling AI status and discuss eligibility

  • Early access customers will be first to run TuneLab models when we launch